Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LFWD Stock Forecast 2025-2026
$0.53
Current Price
$8.39M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to LFWD Price Targets
+2,332.2%
To High Target of $13.00
+1,770.9%
To Median Target of $10.00
+87.1%
To Low Target of $1.00
LFWD Price Momentum
-14.5%
1 Week Change
-36.1%
1 Month Change
-75.9%
1 Year Change
-69.4%
Year-to-Date Change
-86.6%
From 52W High of $4.00
+6.7%
From 52W Low of $0.50
📊 TOP ANALYST CALLS
Did LFWD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if ReWalk is one of their latest high-conviction picks.
Latest LFWD Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, LFWD has a bullish consensus with a median price target of $10.00 (ranging from $1.00 to $13.00). The overall analyst rating is N/A (N/A/10). Currently trading at $0.53, the median forecast implies a 1,770.9% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Swayampakula Ramakanth at HC Wainwright & Co., projecting a 2,332.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LFWD Analyst Ratings
3
Buy
0
Hold
0
Sell
LFWD Price Target Range
Low
$1.00
Average
$10.00
High
$13.00
Current: $0.53
Latest LFWD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LFWD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 11, 2025 | Lake Street | Ben Haynor | Buy | Maintains | $4.00 |
| Mar 11, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Feb 20, 2025 | Lake Street | Ben Haynor | Buy | Maintains | $4.50 |
| Feb 20, 2025 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Feb 10, 2025 | Laidlaw & Co. | Yale Jen | Buy | Initiates | $10.00 |
| Nov 13, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $13.00 |
| Aug 16, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $13.00 |
| May 16, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Maintains | $13.00 |
| Apr 15, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $9.00 |
| Feb 28, 2024 | HC Wainwright & Co. | Swayampakula Ramakanth | Buy | Reiterates | $3.00 |
| Nov 15, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Aug 14, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Aug 10, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jul 3, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| May 12, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Feb 24, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Nov 15, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 10, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Mar 1, 2021 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 13, 2020 | HC Wainwright & Co. | Buy | Maintains | $N/A |
Lifeward Ltd. (LFWD) Competitors
The following stocks are similar to ReWalk based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
LFWD
ReWalk Robotics
mkt cap
9.71M
Lifeward Ltd. (LFWD) Financial Data
Lifeward Ltd. has a market capitalization of $8.39M with a P/E ratio of -0.2x. The company generates $24.43M in trailing twelve-month revenue with a -121.8% profit margin.
Revenue growth is -14.7% quarter-over-quarter, while maintaining an operating margin of -66.0% and return on equity of -114.9%.
Valuation Metrics
Market Cap
$8.39M
Enterprise Value
$4.37M
P/E Ratio
-0.2x
PEG Ratio
0.0x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
-14.7%
Gross Margin
+43.9%
Operating Margin
-66.0%
Net Margin
-121.8%
EPS Growth
-14.7%
Financial Health
Cash/Price Ratio
+61.2%
Current Ratio
2.0x
Debt/Equity
2.5x
ROE
-114.9%
ROA
-28.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Lifeward Ltd. (LFWD) Business Model
About Lifeward Ltd.
What They Do
Provides innovative healthcare solutions and medical devices.
Business Model
Lifeward Ltd. generates revenue by developing, producing, and distributing a wide range of medical devices and health management systems. Their products cater to hospitals, clinics, and home healthcare, focusing on enhancing patient care through advanced technology.
Additional Information
The company plays a significant role in the medical technology sector, with a strong emphasis on patient monitoring and management. Lifeward Ltd. is committed to continuous innovation and quality, aiming to improve healthcare accessibility and efficiency.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
80
CEO
Mr. William Mark Grant
Country
Israel
IPO Year
2014
Website
golifeward.comLifeward Ltd. (LFWD) Latest News & Analysis
Latest News
First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
1 month ago
Quick Summary
Medicare Advantage claims are now processed in under 30 days, and traditional Medicare claims are seeing faster approval timelines set for 2025.
Why It Matters
Faster Medicare claim processing improves cash flow for healthcare providers, potentially boosting their profitability and attractiveness to investors in the healthcare sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
LFWD receives CE mark for the ReWalk 7 Personal Exoskeleton, enabling sales in Europe and highlighting its advanced features.
Why It Matters
LFWD's CE mark for the ReWalk 7 opens access to European markets, enhancing sales prospects and potentially boosting revenue, which can positively impact stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
ReWalk's seventh-generation exoskeleton has received clearance for commercial launch in the European Union, expanding its market presence.
Why It Matters
The commercial launch of the ReWalk Exoskeleton in the EU signals growth potential in assistive technology, potentially boosting the company’s revenue and market position.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Lifeward Ltd. (NASDAQ: LFWD) will host its Q2 2025 earnings conference call on August 14, 2025, at 8:30 AM ET, featuring key executives and analysts from various firms.
Why It Matters
Lifeward Ltd.'s Q2 earnings call may reveal key financial insights and growth strategies, impacting stock performance and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Lifeward Ltd. reports record placements of ReWalk systems for Medicare beneficiaries, with 130 qualified leads. A new CEO and CFO have been appointed to drive strategic growth.
Why It Matters
Record placements of ReWalk systems indicate strong demand and market penetration. New leadership suggests strategic shifts that may enhance growth potential, appealing to investors seeking growth opportunities.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About LFWD Stock
What is Lifeward Ltd.'s (LFWD) stock forecast for 2026?
Based on our analysis of 4 Wall Street analysts, Lifeward Ltd. (LFWD) has a median price target of $10.00. The highest price target is $13.00 and the lowest is $1.00.
Is LFWD stock a good investment in 2026?
According to current analyst ratings, LFWD has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.53. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LFWD stock?
Wall Street analysts predict LFWD stock could reach $10.00 in the next 12 months. This represents a 1,770.9% increase from the current price of $0.53. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Lifeward Ltd.'s business model?
Lifeward Ltd. generates revenue by developing, producing, and distributing a wide range of medical devices and health management systems. Their products cater to hospitals, clinics, and home healthcare, focusing on enhancing patient care through advanced technology.
What is the highest forecasted price for LFWD Lifeward Ltd.?
The highest price target for LFWD is $13.00 from Swayampakula Ramakanth at HC Wainwright & Co., which represents a 2,332.2% increase from the current price of $0.53.
What is the lowest forecasted price for LFWD Lifeward Ltd.?
The lowest price target for LFWD is $1.00 from at , which represents a 87.1% increase from the current price of $0.53.
What is the overall LFWD consensus from analysts for Lifeward Ltd.?
The overall analyst consensus for LFWD is bullish. Out of 4 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $10.00.
How accurate are LFWD stock price projections?
Stock price projections, including those for Lifeward Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 8, 2025 1:17 PM UTC